Summary. Alloxan 5 mM depolarised the islet but not the aeinar cells of mouse pancreatic segments in vitro. This effect was prevented by D-glucose but not by glutathione, 3, 0, methyl-e-D-glucose, D-glucosamine, D-mannoheptulose, or L-leucine. Pretreatment of islet /?-cells with streptozotocin 20 mM caused no depolarization but inhibited the generation of action potentials by D-glucose, L-leueine, D-mannose and D-glyceraldehyde, whereas tolbutamide-induced action potentials were not blocked ; the alkylating moiety of streptozotocin, N-nitroso N-methyl urea produced similar effects. Prior exposure of the islet cells to nicotinamide 4.1 mM conferred protection against streptozotoein action. These observations are discussed in relation to the diabetogenic action of alloxan and streptozotocin.
Introduction
The diabetic state in an animal can be induced permanently by the selective cytotoxic agents Mloxan and streptozotoein. However, the metabolic abnormalities of diabetes mellitus induced by these compounds are not identical, suggesting that they have a different mechanism of action (Nansford and Opie, 1968) . Alloxan is speeificMly taken up by mouse islet tissue and eytologieM changes are visible in fi-eells within 5 min of Mloxan administration (I-Iammarstrom, tIellman and Ullberg, 1966; Lazarus, Burden and Bradshaw, 1962) . The rapid increase in the rate of penetration of ltC-mannitol into toadfish islets indicated that Mloxan altered the permeability of /~-eells (Watkins, Cooperstein and Lazarow, 1964) . Little is known about the mechanism of induction of diabetes by streptozotocin.
Eleetrophysiological studies have shown that ficells from mouse pancreatic islets have a cellular transmembrane potential of --20.1 mV and the resting potential can be affected by exposure to glucose, mannose, leueine and tolbutamide. These substances, which are also known to evoke insulin secretion, induce small action potentials in the islet cells (Dean and Matthews, 1970a; Matthews and Dean, 1970) . Changes in the ionic composition of the extracellulur fluid can influence the electrical characteristics of the action potentials (Dean and Matthews, 1970b) . In this paper the effects of Mloxan and streptozotocin on mouse panereatic islet cell membrane potentials and on electrical activity are described. A parallel study has been made of the action of the compound N-nitroso N-methyl urea, the Mkylating moiety of streptozotocin, on the electrical activity induced by glucose in islet cells.
Methods
The pancreas was removed from albino mice of either sex weighing 30--40 g. A segment of pancreas was placed in a perspex tissue bath and superfused transmembrane potentials according to the methods described previously (Dean and Matthews, 1970a) . Since alloxan, streptozotocin and N-nitroso Nmethyl urea are rapidly decomposed by hydrolysis, solutions of these compounds were made immediately before use and added directly to the tissue bath.
The possible methylation of nieotinamide by streptozotocin was investigated chromatographically. 20 mM streptozotocin and 4.1 mM nicotinamide solutions were incubated at 37~ for 20 rain and a 100 ~L aliquot applied to Whatman No. 1 filter paper. Aliquots (100 ~L) of solutions of nicotinamide 4.1 raM, N-methylnicotinamide 4.1 mM and 1 methyl nieotinamide 4.1 mM were used for comparison. The chromategrams were developed in N-butanol saturated with water, and the spots visualized after exposure to iodine vapour.
Results

Experiments with alloxan
The effect of the addition of alloxan 5 m~ on mouse islet cell membrane potentials is shown in Fig. 1 . Alloxan did not affect the acinar cell membrane potentials, whereas the islet cells showed a rapid, significant, and sustained depolarization from --20.8 mV • S.E.M. 2.4 mV to --8.6 mV4-S.E.M. 1.3 mV (P<0.01).
~
; mV with Krebs-Henseleit solution at 37~ The solution had the following composition: NaC1 103 raM, KC1 4.7 raM, CaCls 2.56 raM, MgC12 1.13 raM, NaHCOs 25 raM, NaHePO4 1.15 mM, D-glucose 2.8 raM, sodium pyruvate 4.9 raM, sodium fumarate 2.7 raM, sodium glutamate 4.9 raM. It was gassed with 95% 02--5% COs. The islets of Langerhans were separated from the surrounding acinar tissue by micro-dissection. Glass micro-electrodes filled with 1.5 M potassium citrate, tip resistance 100 M f~, were used to record the cellular Alloxan did not induce electrical activity in islet cells. Histograms of frequency plotted against membrane potential for impalements obtained during the period 30 to 60 rain after alloxan 5 mM did not reveal a population of islet cells which were resistant to depolarization by alloxan. The results shown in Fig. 2 are the effects of preincubation of islets with glutathione 15 mM, I)-glueose 16.6 mM, L-leucine 15 mM, 3,0-methyl-c~-D-glucose 25.6 mM, D-glueosamine 23.2 raM, or D-mannoheptu-lose 23.8 mlV[, on the depolarization of islet cells normally produced by alloxan 5 raM. The mean membrane potential was measured for impalements obtained during the control period (60 min) before exposure to alloxan (this value is shown on the left column of each histogram). Preincubation with 15 mM g]utathione 15 rain before and during exposure to alloxan 5 mM did not prevent depolarization (values shown in the right-hand column of each histogram were obtained from the period 30--60 min after alloxan administration). In contrast, glucose 16.6 mM, produced complete protection against alloxan. During the superfusion with glucose 16.6 mM action potentials were generated in islet cells (Fig. 2) . Preincubation with Lleueine 15 mM, which also induced action potentials, failed to protect against the depolarization produced by alloxan 5 raM. The strnetural analogues of glucose : 3,0-methyl-~-D-glueose, D-glueosamine and mannoheptulose --an inhibitor of hexokinase, failed to prevent the depolarization of islet cells. These drugs when exposed to the tissue alone, did not produce depolarization.
Experiments with streptozotocin
Streptozotoein is rapidly inactivated by hydrolysis at physiological pII (Garret, 1960) so that the drug could not be superfused over islet cells for more than short time periods.
The islet tissue was perfused for one hour in normal Krebs-Henseleit solution and numerous islet cells were impaled in order to determine a mean value for the membrane potential. A dose of steptozotocin was added directly to the bath to achieve an initial concentration of 20 mM, the membrane potentials were measured, and the mean values obtained for successive 10 rain intervals. During the 60 rain period after exposure to streptozotocin the membrane potential was unchanged (Fig. 3) and streptozotoein did not itself induce electrical activity in islet cells.
Elsewhere it has been shown that D-glucose 11.1 raM, L-leucine 10 raM, D-mannose 16.6 mM and Dglyceraldehyde 11 mM each induce electrical activity in islet cells (Dean and Matthews, 1970a; Matthews and Dean, 1970; Dean and Matthews, 1971 ). This type of activity was characterized by bursts of action potentials occurring at 10 s intervals; the action potentials had an amplitude of 1--4 mV and a duration of 50 mS. Tolbutamide 0.7 mM, however, induced continuous firing of longer duration action potentials at a rate of about 1 per sec, 250 ms duration and amplitude 1--8 mV.
The effect of streptozotocin on action potential generation was studied as follows. Measurements of islet cell membrane potentials were made during a 60 min control period in normal Krebs-I-Ienseleit solution containing the stimulating agent, e.g. D-glucose 11.1 mN[ and the fraction of impaled cells which produced electrical activity was noted; this procedure was repeated on several islet preparations. In further experiments, membrane potentials were measured during a control period, then, after a single dose of streptozototin corresponding to a peak bath concentration of 20 mM, membrane potentials were measured during the next 60 min; the preparation was subsequently superfused for 30 rain with glucose 11.1 mM (or other stimulating agent) and the fraction of cells exhibiting action potentials during this 30 rain period was observed. The results expressed in Table 1 show that pretreatment with streptozotoein inhibited the generation of action potentials by D-glucose, L-leucine, D-mannose and D-glyceraldehyde, whereas tolbutamide-induced action potentials were not blocked by pretreatment with streptozotoein. Nicotinamide injected intravenously into mice protects against the diabetogenic properties of streptozotocin (Schein and Bates, 1968) . After obtaining control values of membrane potentials in normal KrebsHenseleit solution, the cells were exposed to solution containing nieotinamide 4.1 mM 15 rain before addition of streptozotocin 20 raM; 60 min later solution containing glucose 11.1 mM was perfnsed over the tissue for 30 rain. Glucose induced firing in 83% of the impaled islet cells showing that nicotinamide conferred protection against streptozotocin. Exposure to nieotinamide 4.1 mM alone did not generate action potentials or change the resting membrane potential.
The effect of N-nitroso N-methyl urea was investigated for comparison with streptozotocin. Membrane potentials were measured in normal Krebs-Henseleit solution during a 60 min control period, then N-nitroso N-methyl urea was added to the bath to produce a Diabetologia peak concentration of 20 mlYi and the preparation was superfused for 60 min. When the tissue was exposed to a solution containing D-glucose 11.1 raM, action potentials were induced in only 3.5% of the cells. On the other hand with tolbutamide 0.7 mN as a stimulating agent, action potentials with characteristics typical of tolbutamide were produced in 50% of the cells. (Table 1 ).
Paper chromatography showed that incubation of streptozotocin 20 mN with nicotinamide 4.1 mM produced a single spot with an RF value of 0.65; nicotinamide itself had an t~r value of 0.66. No spots were found corresponding to N-methyl nicotinamide (RF accompanying changes in islet cell permeability to ~4C-mannitol (Watkins, Cooperstein and Lazarow, 1964) . In contrast, streptozotocin did not alter islet cell membrane potentials during the 90 min period of exposure; the earliest cytological ehanges are apparently observed only after 2 h (Brosky and Logothetopoulos, 1969) .
Of the substances tested, only D-glucose protected islet cells against depolarization by alloxan. There is no evidence for inactivation of alloxan by glucose (Webb, 1966) . Since D-glucose, D-fructose and Dmannose given in vivo protect against alloxan diabetes (Bhattaeharya, 1953; 1954) and all three hexoses are 0.82) or 1-methyl nieotinamide (RF 0.05). Therefore, the possibility of simple chemical inactivation of streptozotoein, with nicotinamide acting as an acceptor for the free methyl radical, seems unlikely.
Discussion
Alloxan rapidly and selectively depolarized the cells from mouse islets of Langerhans. In contrast, guinea-pig islet cells, which are known to be resistant to the diabetogenic properties of alloxan (Maske and Weinges, 1957) , are not depolarized by Mloxan (Dean and Matthews, 1968) . The rate of onset of depolarization by alloxan, an effect occurring within l0 min, correlates well with the time course of cytological changes which are: a diminution in nuclear and cytoplasmic granules, vacuolation and shrinkage of cytoplasm (Lazarus, Barden and Bradshaw, 1962) , with metabolized by hexokinase, it was thought that alloxan might act by inhibiting hexokinase. However, VillarPalasi, Carbadillo, Sols and Arteta (1957) showed that the ratio of the protective properties of D-glucose, Dmannose and D-fructose did not correspond to the affinity of these hexoses for pancreatic hexokinase. The glucose analogues 3,0-methyl-~-D-glueose and D-glueosamine did not confer protection, neither did D-mannoheptulose which is a specific inhibitor of hexokinase. Since glucose induced action potentials in islets, the possibility occurred that some property related to the action potential discharge could have produced the protection. However, this is improbable because L-leucine, which also induced action potentials, did not protect the islet cells from the depolarizing influence of alloxan. Although glutathione given in vivo protects against alloxan diabetes (Lazarow, 1946) , no in vitro protection was observed.
Pretreatment of islet cells with streptozotoein destroyed the ability of the cells to generate action potentials when stimulated by D-glucose, D-mannose, L-leucine or D-glyceraldehyde. It has recently been shown that preincubation of isolated islets of Langerhans with streptozotoein inhibits glucose-induced insulin secretion (Golden, Baird, Malaisse, Malaisse-Lagae and Walker, 1971) . Induction of electrical activity with tolbutamide was not inhibited by streptozotocin.
In vivo experiments with mice pretreated with streptozotocin have shown that tolbutamide reduces the diabetic hyperglycemia, probably by releasing insulin (gerup and Tarding, 1969) . Streptozotocin can therefore distinguish between the two ionic mechanisms in the fl-cell membrane by inhibiting fast action potentials characteristic of D-glucose, L-leueine, D-mannose and D-glyeeraldehyde, whilst not markedly affecting the slower action potentials produced by tolbutamide.
Pretreatment with nicotinamide protects isolated rat islets of Langerhans, and the whole animal, against the diabetogenic action of streptozotoein (Schein and Bates, 1968 ; Sehein, Cooney and Vernon, 1967 ; Golden, Baird, Malaisse, Malaisse-Lagae and Walker, 1971) . Streptozotoein produces a depression of NAD and NADI-I levels in mouse liver; this depression is prevented by nieotinamide administered before the dose of streptozotoein (Schein and Loftus, 1968) . It is not known, however, whether streptozotoein produces diabetes by affecting NAD levels in fi-eells, although our results and those of Golden et al. (1971) suggest this possibility.
N-Nitroso N-methyl urea is alleged to be nondiabetogenic (Sehein and Loftus, 1968) . However, in vitro a single dose of N-nitroso N-methyl urea had a similar effect to streptozotoein by inhibiting action potentials when islet cells were subsequently exposed to glucose. Similarly N-nitroso N-methyl urea did not inhibit action potentials generated by tolbutamide. The close resemblance between the effects of N-nitroso N-methyl urea and streptozotoein might suggest a similar mode of action on islet cells.
The primary target for the cellular effect of streptozotoein is unknown; specific inhibition of the glueoreceptor appears unlikely since action potentials elicited with the structurally dissimilar substances, L-leucine and D-glyeeraldehyde are also blocked. The mechanism of insulin secretion is not necessarily destroyed since the hypoglyeemie effect of tolbutamide and action potential genesis still occur after pretreatment with streptozotoein. As the effect of streptozotocin on electrical activity can be mimicked by N-nitroso N-methyl urea it is probable that the N-nitroso Nmethyl urea moiety of streptozotoein causes diabetes, the glucose moiety acting to confer high specificity for the fl-eell, since these cells must have a very specialized mechanism for reeognising and handling glucose molecules. Magee and Schoental (1964) have suggested that alkyl nitroso compounds react with cell thiol groups with the eventual liberation of a methyl radical. The free methyl radical is then able to methylate any free sulphydryl or carboxylie groups.
How alloxan causes islet Bells to depolarize is not yet known. Inhibition of energy production as the primary effect of alloxan seems improbable because dinitrophenol, which is believed to inhibit the production of ATP in mammalian cells, does not depolarize the islet cells (Dean and Matthews, 1970a) . Alloxan is normally transported into islet cells, but not in cells obtained from mice resistant to alloxan (Hammarstrom, st al., 1966) , suggesting that the cytotoxieity of alloxan is dependent on uptake into the islets. Since alloxan causes a rapid permeability change it is possible that it reacts directly with a specific membrane component, possibly through the highly reactive earbonyl grouping at position 5. The binding of glucose to the membrane may induce a eonformational change in the alloxan carrier mechanism, thereby preventing alloxan from entering the Bell to exert cytological damage (Sehneyius and T/~ljedal, 1971) . However, the precise molecular mechanism for the production of diabetes by either alloxan or streptozotocin remains to be elucidated.
